Evidence map›Paper›PMID 31289903›Full record

ArticleApplied microbiology and biotechnology2019

High-density immobilization of a ginsenoside-transforming β-glucosidase for enhanced food-grade production of minor ginsenosides.

Chang-Hao Cui, Byeong-Min Jeon, Yaoyao Fu, Wan-Taek Im, Sun-Chang Kim

Open access · hybridAbstract read
In one paragraph

Article in Applied microbiology and biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Pharmacological activities of ginsenoside Rg5 (Review).Experimental and therapeutic medicine · 2021
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Chang-Hao CuiIntelligent Synthetic Biology Center, 291 Daehak-Ro, Yuseong-Gu, Daejeon, 305-701, Korea.
Byeong-Min JeonDepartment of Biological Sciences, Korea Advanced Institute of Science and Technology, 291 Daehak-Ro, Yuseong-Gu, Daejeon, 305-701, Korea.
Yaoyao FuThe Key Laboratory of Biotechnology for Medicinal Plant of Jiangsu Province, Jiangsu Normal University, No. 101 Shanghai Road, Xuzhou, Jiangsu, 221116, People's Republic of China.
Wan-Taek ImDepartment of Biological Sciences, Hankyong National University, 327 Chungang-Ro, Anseong City, Kyonggi-Do, 456-749, Korea.
Sun-Chang KimIntelligent Synthetic Biology Center, 291 Daehak-Ro, Yuseong-Gu, Daejeon, 305-701, Korea. sunckim@kaist.ac.kr.
Korea Advanced Institute of Science and Technology · KRHankyong National University · KRIntelligent Synthetic Biology Center · KRJiangsu Normal University · CN

Funding

Intelligent Synthetic Biology Center of Global Frontier Project 2011-0031957
6 · The paper itself

Abstract

Use of recombinant glycosidases is a promising approach for the production of minor ginsenosides, e.g., Compound K (CK) and F

Indexed as

ActinomycetalesBacterial Proteinsbeta-GlucosidaseBiotransformationCelluloseCloning, MolecularCorynebacterium glutamicumEnzymes, ImmobilizedGene ExpressionGinsenosidesRecombinant Fusion ProteinsSapogeninsBacterial Proteinsbeta-GlucosidaseCelluloseEnzymes, Immobilizedginsenoside-beta-glucosidaseginsenoside compound Kginsenoside F1GinsenosidesprotopanaxadiolprotopanaxatriolRecombinant Fusion ProteinsSapogeninsBiotransformationCompound KCorynebacterium glutamicumDeglycosylationGinsenoside F1

Identifiers

PMID31289903
PMCPMC6690934
OpenAlexW2959103808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.